From: The emerging role of the long non-coding RNA HOTAIR in breast cancer development and treatment
Component | Drug category | Effect on HOTAIR | Comment | References |
---|---|---|---|---|
Calycosin | Phytostrogen isoflavon | Down-regulation | Induces apoptosis by down-regulating phosphorylation of HOTAIR upstream target, Akt | [116] |
Genistein | Soy isofalvone | Down-regulation | Represses HOTAIR as well as NF-κB and Akt signalling pathways, while it overexpresses miR-141 | |
BIO | Genistein nano-suspension | Down-regulation | Inhibits GSK3β and induces β-Catenin signalling, leading to down-regulation of HOTAIR | [37] |
Delphinidin-3-glucoside | Anthocyanidin | Down-regulation | Induces apoptosis via activation of IRF1 and repression of Akt | [53] |
Imatinib + Lapatinib | Anti-neoplastic agent | Down-regulation | Synergistically supress β-Catenin and subsequently HOTAIR expression | [117] |
BML-284 | Wnt agonist | Down-regulation | Induces Wnt/β-Catenin signalling pathway and repression of HOTAIR | [37] |
Bisphenol-A | estrogenic endocrine disrupting chemical | Up-regulation | Interferes with normal estrogen signalling pathway, leading to expression of HOTAIR by inducing the corresponding ERE promoter, in addition to particular histone modifications | [95] |
Diethylstilbestrol | Synthetic estrogen | Up-regulation | Involved in normal estrogen signalling pathway and HOTAIR expression, through interaction with the corresponding ERE promoter and particular histone modifications | [95] |
Gemcitabine | Anti-metabolite agents | Up-regulation | Through unknown mechanism, this agent up-regulates HOTAIR causing further malignant cell proliferation, self-renewal and migration | [104] |